Lamotrigine: uses, dosing, side effects & brands

Lamictal (Lamotrigine) is an anti-epileptic agent used to treat Bipolar Disorder, Partial Epilepsies, Seizures, Lennox Gastaut Syndrome.

The FDA classifies lamotrigine as an anti-epileptic agent. Anti-epileptic (anticonvulsant) drugs calm the abnormal, excessive electrical activity that triggers seizures. They do this by stabilizing overactive sodium or calcium channels in nerve cells, boosting the brain's natural calming chemical GABA, or dampening excitatory signals, which makes nerves less likely to fire uncontrollably. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

The label directs that lamotrigine not be stopped abruptly. Under Warnings and Precautions (5.10, 'Withdrawal Seizures'), it states that as with other antiepileptic drugs, abrupt discontinuation carries a risk of increased seizure frequency in patients with epilepsy; in bipolar-disorder trials, 2 patients had seizures shortly after abrupt withdrawal. Unless safety concerns require faster withdrawal, the label instructs a prescriber-managed, step-wise taper over a period of at least 2 weeks (about a 50% dose reduction per week). This taper instruction is repeated in Dosage and Administration. It is a discontinuation/taper directive, not a boxed warning (the boxed warning covers serious skin rashes). Do not stop lamotrigine on your own — any change is a prescriber-managed decision.

The elimination half-life of lamotrigine is about 25 to 33 hours in healthy adults taking no other medications — the label reports a mean elimination half-life of 32.8 hours after a single dose (individual range 14 to 103 hours) and 25.4 hours with repeat dosing (range 11.6 to 61.6 hours), since lamotrigine induces its own metabolism — that is how long the body takes to clear half of a dose. These are the terminal (elimination) half-life values from Table 14 of the label; lamotrigine is not a prodrug and has no active metabolite that outlasts it — the label states the major metabolite, the 2-N-glucuronide, is inactive. The half-life shifts a lot with other drugs and with organ function. Other seizure medicines that induce liver enzymes (carbamazepine, phenytoin, phenobarbital, primidone) shorten it to roughly 13 to 14 hours, while valproate roughly doubles it (about 48 hours single-dose, about 70 hours with repeat dosing in healthy volunteers); lopinavir/ritonavir cuts it by roughly half. Older adults: essentially unchanged — mean 31.2 hours (range 24.5 to 43.4) in volunteers aged 65 to 76. Kidney impairment: prolonged — mean 42.9 hours in chronic renal failure and 57.4 hours between hemodialysis sessions, versus 26.2 hours in the healthy controls in that same study (13 hours during a dialysis session, which removes about 20% of drug in the body over 4 hours). Liver impairment: markedly prolonged — mean half-life 46 hours (mild), 72 hours (moderate), 67 hours (severe without ascites) and 100 hours (severe with ascites). This is pharmacokinetic information, not dosing guidance and not a drug-test detection window. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run lamotrigine against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

We track 6 lamotrigine-containing products in the U.S.: Lamictal, Lamictal Cd, Lamictal ODT, Lamictal XR, Lamotrigine and Subvenite. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

Across the brands we track, lamotrigine is currently marketed as tablet, kit, tablet, orally disintegrating, tablet, extended release, tablet, chewable and suspension, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Yes. Our catalog lists 1 generic lamotrigine product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

Dizziness, headache, double or blurred vision, unsteadiness, nausea, and sleepiness are the most commonly reported reactions in epilepsy trials; in bipolar disorder the list is nausea, insomnia, sleepiness, back pain, fatigue, and dry mouth. Most of these are dose-related and mildest during the slow starting titration, which is one reason the titration exists. Double vision and unsteadiness in particular tend to track your peak blood level — they often improve if the dose is split or lowered, which is a conversation to have rather than something to tough out. Taking it with food can help nausea. Sleepiness or insomnia is worth reporting because the dosing time can usually be shifted.

Any new rash while starting lamotrigine means stop and call your prescriber the same day. Lamotrigine can cause life-threatening rashes including Stevens-Johnson syndrome and toxic epidermal necrolysis; serious rash requiring hospitalization occurs in roughly 0.3–0.8% of children aged 2–17 and 0.08–0.3% of adults. Nearly all cases appear within the first 2 to 8 weeks, though isolated cases have occurred after months. Go to an emergency room if rash comes with fever, swollen glands, blisters, peeling skin, sores in the mouth, eyes, or genitals, painful skin, or swelling of the face or lips. Risk is higher with valproate, with a starting dose above the recommended one, with faster-than-recommended escalation, and in people carrying HLA-B*1502 — though cases have occurred without any of these.

No, not without asking first. The label ties the answer to how fast you clear the drug: if you have been off lamotrigine for longer than 5 half-lives, restart with the initial dosing and titration schedule rather than your maintenance dose. You cannot do that arithmetic at home, because your half-life depends on what else you take — valproate lengthens it substantially, while carbamazepine, phenytoin, phenobarbital, primidone, and rifampin shorten it, in some cases to a couple of days. Resuming your old dose after a gap can amount to exceeding the recommended starting dose, one of the named risk factors for serious rash. So after any missed stretch of days, call the prescriber or pharmacist before taking the next pill. The same caution applies at the other end: don't stop abruptly either, because that can trigger withdrawal seizures — the label recommends tapering by about 50% per week over at least two weeks unless a safety problem forces faster withdrawal.

Fever with swollen glands, especially 8 to 24 days after starting, can signal hemophagocytic lymphohistiocytosis (HLH), a life-threatening immune reaction. Fever plus rash plus swollen glands with liver, kidney, heart, or muscle involvement can mean multiorgan hypersensitivity (DRESS), which has caused fatal organ failure. Headache with a stiff neck, fever, nausea, and vomiting can mean aseptic meningitis. Repeated infections, unusual bruising, or paleness may reflect blood dyscrasias including neutropenia, anemia, or rarely aplastic anemia. Report new or worsening suicidal thoughts — this applies to anti-seizure drugs as a class. And because lamotrigine has class IB antiarrhythmic activity in laboratory testing, tell your prescriber if you have structural or functional heart disease, valve disease, arrhythmias, or a cardiac channelopathy.

Valproate roughly doubles lamotrigine levels — that's why the starting dose is much lower in people on valproate, and why the combination carries extra rash risk. Estrogen-containing birth control does the opposite, speeding lamotrigine clearance, so starting, stopping, or the hormone-free week of a pill pack can swing your level and either bring back symptoms or bring on side effects. Carbamazepine, phenytoin, phenobarbital, primidone, and rifampin also push levels down. Anytime a clinician adds or removes one of these — including a new birth control prescription from a different office — say out loud that you take lamotrigine, so the dose gets reviewed rather than left to drift.